Review

Fibrosis-Driven Cardiovascular Risk in Metabolic Dysfunction-Associated Steatotic Liver Disease: Emerging Links With Atherosclerotic Cardiovascular Disease

Figure 1. PRISMA flow diagram of the study selection process.
Open the figure at full size
Figure 1. PRISMA flow diagram of the study selection process.PRISMA flow diagram of the study selection process.Mahajan et al.

Cureus

The paper

Maimonides Medical Center · Queens Hospital Center

Cureus · 31 Aug 2026

doi.org/10.7759/cureus.115501PubMed 42819336

More on GLP-1 receptor agonists